Status:
COMPLETED
Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Covid19
Vaccine Refusal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to increase uptake of the COVID booster vaccine through messaging informed by Construal Level Theory. Patients in the Mass General Brigham (MGB) health system aged 18 and older who are...
Eligibility Criteria
Inclusion
- Patients in the Mass General Brigham system
- Aged 18 and older
- Are eligible for the COVID booster vaccine but have not received a dose at time of upcoming primary care clinic visit
Exclusion
- Documented allergy to a COVID vaccine or its components
- Home address outside of Massachusetts
- Did not receive full set of primary COVID-19 vaccination series
Key Trial Info
Start Date :
February 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2022
Estimated Enrollment :
3671 Patients enrolled
Trial Details
Trial ID
NCT04871776
Start Date
February 18 2022
End Date
August 17 2022
Last Update
January 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mass General Brigham
Boston, Massachusetts, United States, 02120